MD Anderson News Release 01/30/14
When comparing treatments designed to enable long-term breast preservation for older women with invasive breast cancer, researchers found those treated with brachytherapy were at higher risk for a later mastectomy, compared to women treated with standard radiation therapy. The research was led by The University of Texas MD Anderson Cancer Center.
The findings, published in the International...
Researchers at MD Anderson, Baylor College of Medicine lead Cancer Genome Atlas project
MD Anderson News Release 01/29/...
Rivals’ relative expression levels in cancer cells could be biomarkers for prognosis, treatment
MD Anderson News Room 01/23/14
MD Anderson News Room 01/21/14
The University of Texas MD Anderson Cancer Center will collaborate with Johnson & Johnson Innovation, LLC, and its affiliate Janssen Biotech, Inc., to develop immunology-based cancer treatments through the MD Anderson Moon Shots Program immunotherapy platform.
“The strengths of both organizations in the rapidly growing field of cancer immunotherapy can exploit opportunities to develop...
Study followed head and neck cancer patients looking for signs of dehydration, a common and sometimes dangerous side-effect
MD Anderson News Release 01/14/14
Fifty years ago this month, The U.S. Surgeon General jumpstarted America’s efforts to combat...
IMRT reduces side effects, also improves outcomes
MD Anderson News Release 01/12/2014
Patients with cancers of...
unprecedented assault on cancer
MD Anderson News Release 01-10-14
The University...
Some surprising research findings from scientists at The University of Texas MD Anderson Cancer Center suggest it’s possible...
Alliance aims to accelerate and improve new treatments through MD Anderson’s Moon Shots Program immunotherapy platform, led by...